Please try another search
Biolight Life Sciences Ltd, formerly Bio Light Israeli Life Sciences Investments Ltd, is an Israel-based company engaged, through its subsidiaries, in various fields of research and development of pharmaceuticals and medical products and devices. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The Company provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.
Name | Age | Since | Title |
---|---|---|---|
Suzana Nahum-Zilberberg | 52 | 2011 | Vice Chairman of the Board |
Ron Neumann | 68 | 2019 | Chief Medical Officer & Member of Scientific Advisory Board |
Rina Shafir | 60 | 2018 | Independent External Director |
Israel Makov | 84 | 2011 | Chairman of the Board |
Jacob Faigenbaum | 70 | 2017 | Independent Director |
Ron Mayron | 60 | 2015 | Independent Director |
Anat Loewenstein | - | - | Member of Scientific Advisory Board |
Alla Felder | 50 | 2020 | Independent External Director |
Jeffrey Goldberg | - | - | Member of Scientific Advisory Board |
Joseph Tauber | - | - | Member of Scientific Advisory Board |
Vincente Anido | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review